InvestorsHub Logo

Lemoncat

08/07/21 3:22 PM

#369336 RE: farrell90 #369334

Good info, thanks. So depending on how much of that was milestone payments probably somewhere in the 15-20% area. In that case the terms on the BioNtech deal would be stellar for IPIX. Even if therapeutics are 10% of the Pfizer vaccine, $50M/quarter would be a massively funded company ready to develop several other indications in parallel.

Go IPIX!